The Journal of the Pharmacy Society of Wisconsin
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2025
    • JPSW 2024
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Submit a Manuscript
  • Contact
    • Editorial Advisory Committee

Review of Effect of Tirzepatide on Glycemic Control and Weight Loss

by Rachael L. Koch, 2023 PharmD Candidate, Rachel K. Schneider, 2023 PharmD Candidate, Megan A. Mills, 2023 PharmD Candidate, Michael W. Nagy, PharmD, BCACP 

Tirzepatide (Mounjaro) is a new to market glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist. It has shown to substantially decrease hemoglobin A1c as demonstrated in the SURPASS trials. Additionally, the SURMOUNT-1 trial showed the impact tirzepatide can have on weight reduction independent of diabetes. Tirzepatide has just been implemented into the American Diabetes Association guideline recommendations for type 2 diabetes management with emphasis on weight reduction as of 2023. The current clinical data and upcoming trials have promising evidence to make a significant impact for patients with type 2 diabetes and/or obesity. In this article, we review the clinical trial data for tirzepatide and the applications for pharmacy practice.


Keywords: Tirzepatide, Glycated Hemoglobin, Diabetes Mellitus, Type 2, Gastric Inhibitory Polypeptide, Glucagon-Like Peptide 1, Glucose​​

​
Download PDF

2023 May/June Table of Contents 

The Journal of the Pharmacy Society of Wisconsin (ISSN 2837-8229)


Past Issues

2025
2024

2
023
2020
2021
​2022
2019
2018
2017

About PSW

www.pswi.org

Contact Us

[email protected]
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2025
    • JPSW 2024
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Submit a Manuscript
  • Contact
    • Editorial Advisory Committee